Acumen Pharmaceuticals (ABOS) Non Operating Interest Expenses (2021 - 2026)
Acumen Pharmaceuticals (ABOS) reported Non Operating Interest Expenses of $1.09 million for Q2 2026, up 4.6% from $1.05 million a year earlier and up 2.3% from the prior quarter.
Powered by 
Analysis
Acumen Pharmaceuticals (ABOS) Non Operating Interest Expenses (2021 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Acumen Pharmaceuticals' Non Operating Interest Expenses came in at $4.32 million, up 4.5% year-over-year; for FY2025, it came in at $4.22 million, up 3.8% from FY2024.
- By year, Non Operating Interest Expenses came in at $4.07 million in FY2024 (+600.2%) and $581,000 in FY2023.
- The Q2 2026 figure ranks as the highest quarterly Non Operating Interest Expenses in data going back to Q3 2021.
- Year over year, Non Operating Interest Expenses has now increased in each of the last seven quarters, with growth averaging 14.7% over the last seven quarters.
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.07 million (Q1 2026), $1.09 million (Q4 2025) and $1.07 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Acumen Pharmaceuticals | 160.54 Mn | 160.54 Mn | - | 1.09 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.09 Mn |
| Mar 31, 2026 | 1.07 Mn |
| Dec 31, 2025 | 1.09 Mn |
| Sep 30, 2025 | 1.07 Mn |
| Jun 30, 2025 | 1.05 Mn |
| Mar 31, 2025 | 1.02 Mn |
| Dec 31, 2024 | 1.04 Mn |
| Sep 30, 2024 | 1.03 Mn |
| Jun 30, 2024 | 1.00 Mn |
| Mar 31, 2024 | 1.00 Mn |
| Dec 31, 2023 | 581,000.00 |
| Sep 30, 2021 | 23,000.00 |
API Access
Acumen Pharmaceuticals Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=ABOS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "ABOS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=ABOS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();